Search results
Antonio Colombo
Job title: Director, Cardiac Cath Lab and Interventional Cardiology Unit
Author
Author(s):
Santiago Garcia
Added:
1 year ago
TCT 22 - Dr Santiago Garcia (Minneapolis Heart Institute at Abbott Northwestern Hospital, MN, US) joins us to discuss the findings of a substudy of the PARTNER 3 Trial which aimed to evaluate the safety and efficacy of Edwards' SAPIEN 3 Ultra transcatheter heart valve in aortic stenosis patients with a failing bioprosthetic valve.
In this study, 125 patients received TAVR using the Sapien 3…
View more
Author(s):
Katrina Mountfort
Added:
3 years ago
The growing epidemic of cardiovascular disease, together with an ageing population represents a substantial clinical challenge that stretches healthcare budgets. There is an urgent need for both interventions focused on prevention and treatment innovations. In two sessions of presentations at EuroPCR on the 20th May 2014 in Paris, companies presented their latest innovations. The aim of these…
View more
Jonathan Jiunn Liang Yap
Research Area(s) / Expertise:
Job title: Consultant Cardiologist
Author
Author(s):
Mirvat Alasnag
Added:
10 months ago
EuroPCR 23 — We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of three late-breaking trials that are expected to have a impact on interventional science and clinical practice.
Trials covered in detail include:
EBC TWO Five Year Follow-Up: Two-Stent Vs One for Large Bifurcation Lesions
BASILICA Vs Chimney-Stenting for TAVR-Related Coronary…
View more
Amyloid Heart Disease
Author(s):
Yaser Nemshah
,
Alex Clavijo
,
Gyanendra Sharma
Added:
3 years ago
Article
Author(s):
Justin P Sheehy
,
Adnan K Chhatriwalla
Added:
3 years ago
TCT 23: WATCH-TAVR
Author(s):
Samir R Kapadia
Added:
4 months ago
Video
Author(s):
David J Cohen
Added:
2 years ago
Dr David J Cohen (St Francis Hospital, Roslyn, NY, US) discusses the findings from PARTNER 3 Economic Study. The study, presented first at TCT 2021, showed that for patients with severe AS and low surgical risk, TF-TAVR with the SAPIEN 3 valve is cost-saving compared with SAVR at 2-year follow-up.
Discussion Points
Importance of the Study
Used Data
Complexities in Relation to the Costs of…
View more
PCI in Women
Author(s):
Mirvat Alasnag
,
Valeria Paradies
,
Nicola Ryan
,
et al
Added:
4 months ago
Article